Medcenter Nova Clinic Ltd.

At Medcenter Nova Clinic Ltd., research focuses on cardiovascular diseases such as atherosclerotic cardiovascular disease, atrial fibrillation, and high cholesterol, aiming to evaluate new treatments that reduce heart attacks, stroke risk, and improve heart rhythm.

• New therapies for cholesterol management
• Innovative approaches to reduce cardiovascular events
• Strategies for rhythm control in atrial fibrillation

The site in Varna, Bulgaria, leverages a multidisciplinary team to advance cardiovascular health.

The clinic conducts studies on respiratory tract diseases, particularly moderate to severe chronic obstructive pulmonary disease (COPD), comparing inhaled formulations to improve lung function and quality of life.

• Comparison of inhaler propellants for COPD treatment
• Assessment of lung function outcomes
• Safety and efficacy of new bronchodilator combinations

Participants benefit from access to cutting‑edge respiratory research at the facility.

Research at the site includes investigations into immune system diseases such as Graves’ disease and Sjögren’s disease, focusing on therapies that restore hormonal balance and reduce autoimmune activity.

• Evaluation of monoclonal antibodies for Sjögren’s disease
• Testing novel agents for thyroid autoimmunity
• Long‑term safety of immunomodulatory treatments

The program supports patients with autoimmune conditions through innovative clinical trials.

Clinical trials address nutritional and metabolic diseases, including type 2 diabetes, obesity, and hyperlipidemia, with the goal of testing weekly insulin regimens, weight‑loss agents, and cholesterol‑lowering drugs.

• Weekly insulin therapy for better glycaemic control
• Weight‑loss interventions for obesity management
• Agents targeting LDL‑C reduction

The facility’s metabolic research aims to improve long‑term health outcomes for patients.

The center also supports research in eye diseases, aiming to improve diagnostic tools and therapeutic options, though specific studies are in early development.

• Exploration of novel ocular drug delivery
• Assessment of visual function outcomes
• Safety profiling of emerging eye treatments

Ongoing work seeks to bring innovative eye care solutions to the region.